# Analysis of the Feasibility of Concurrent Application of Magnetic Nanoparticles as MRI Contrast Agents and for Magnetic Hyperthermia

## TL;DR

This paper investigates whether magnetic nanoparticles can be used at the same time for MRI imaging and cancer treatment through heat.

## Contribution

The study identifies a diameter range where nanoparticles are effective for both MRI contrast and hyperthermia.

## Key findings

- Nanoparticle diameters of 20–25 nm show maximum r2 relaxivity for MRI.
- The same diameter range also shows maximum losses for magnetic hyperthermia.
- The study used TEM, DLS, and calorimetric measurements to analyze nanoparticle properties.

## Abstract

The aim of the article was to analyze the potential simultaneous use of magnetic nanoparticles as contrast agents in MRI imaging and for magnetic hyperthermia. The study proposed characterizing the nanoparticles using various measurement methods in order to investigate the relationships between different properties. The first stage involved measuring images of nanoparticle samples using scanning transmission electron microscopy (TEM) and dynamic light scattering (DLS). The diameter distribution of nanoparticles was determined based on image segmentation. The next step involved measuring relaxation properties of nanoparticles in low and high magnetic fields. The research was carried out for nanoparticle solutions of various concentrations and properties. The last step was measuring calorimetric properties of nanoparticles as a thermal source under alternating magnetic field excitation conditions. The range of nanoparticle diameters (20–25 nm) for which maximum losses occur in an alternating magnetic field corresponds to the diameter range in which the maximum r2 relaxivity is observed.